Answers are grounded in this paper and cite their sources.
Background Multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1, OMIM: 614,080) is an autosomal recessive disorder caused by biallelic pathogenic variants in PIGN . The reported PIGN variants are mostly missense, splicing and nonsense mutations, whereas structural variants of PIGN have not been reported. Methods Trio whole-genome sequencing (WGS) was performed to identify the causative variant in the proband and his parents. The tandem duplication was validated by breakpoint-specific junction PCR and Sanger sequencing. Reverse transcription PCR (RT-PCR) and Sanger sequencing were used to characterize the duplicated transcripts, followed by in silico reconstruction of the duplicated cDNA and prediction of its protein sequence. Quantitative reverse-transcription PCR (RT-qPCR) was performed to evaluate PIGN mRNA expression. Results We report a biallelic intragenic tandem duplication of PIGN covering exons 2–22 in a 1-month-old Chinese infant who presented with seizures, hypotonia, facial dysmorphism and multisystem congenital anomalies. Whole-genome sequencing identified a biallelic tandem duplication of PIGN in the proband, with both nonconsanguineous parents carrying the same duplication in the heterozygous state. The rearrangement was further validated by breakpoint-specific junction PCR and Sanger sequencing. Breakpoint analysis identified a 5-bp microhomology sequence (AGGTG) at the duplication-specific junction, consistent with a possible microhomology-mediated rearrangement mechanism. Transcript analysis of the parental carriers confirmed an abnormal exon 22–exon 2 junction, and exploratory RT-qPCR analysis showed lower PIGN mRNA expression in the carriers than in an unrelated healthy control. Conclusions This study expands the mutational spectrum of PIGN and informs the molecular diagnosis of MCAHS1. Our findings highlight the value of whole-genome sequencing in identifying intragenic copy-number and structural variants, and support the consideration of exon-level CNV/SV analysis in patients with clinical features suggestive of MCAHS1 when initial genetic testing is inconclusive.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: